Translate

Τρίτη 21 Απριλίου 2020

M

Atlas Sampling for Prone Breast Automatic Segmentation of Organs at Risk: The Importance of Patients’ Body Mass Index and Breast Cup Size for an Optimized Contouring of the Heart and the Coronary Vessels
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Objective:Delineation of organs at risk is a time-consuming task. This study evaluates the benefits of using single-subject atlas-based automatic segmentation of organs at risk in patients with breast cancer treated in prone position, with 2 different criteria for choosing the atlas subject. Together with laterality (left/right), the criteria used were either (1) breast volume or (2) body mass index and breast...
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
Tue Apr 21, 2020 13:27
Robust Optimization of SBRT Planning for Patients With Early Stage Non-Small Cell Lung Cancer
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Purpose:Setup uncertainty is a known challenge for stereotactic body radiotherapy planning. Using the internal target volume-based robust optimization was proposed as a more accurate way than the conventional planning target volume-based optimization when considering the robustness criteria. In this study, we aim to investigate the feasibility of internal target volume-based robust optimization in stereotactic...
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
Tue Apr 21, 2020 13:25
MiR-203a-3p Inhibits Pancreatic Cancer Cell Proliferation, EMT, and Apoptosis by Regulating SLUG
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Objective:The aim of the present research is to study the roles of miR-203a-3p on cell proliferation, migration, invasion, and epithelial–mesenchymal transition in pancreatic cancer.Methods:Transcription profiles were acquired from Gene Expression Omnibus database, which was used to screen out the differentially expressed microRNAs and messenger RNAs in pancreatic cancer. Pancreatic cancer tissues were used to...
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
Fri Apr 17, 2020 12:32
Knockdown of Rab9 Suppresses the Progression of Gastric Cancer Through Regulation of Akt Signaling Pathway
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Rabs have been reported to be involved in the carcinogenesis process and in the progression of cancer. However, it is unclear whether or not Rab9 is associated with the development of cancer. In the present study, we aimed to investigate the role of Rab9 in the biological functions of gastric cancer cells. The gastric cancer cell lines AGS and MKN45 were transfected with siRNA-Rab9 to block the expression of Rab9....
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
Fri Apr 17, 2020 12:29
Circulating Tumor Cells and Fibronectin 1 in the Prognosis of Nasopharyngeal Carcinoma
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Objective:Nasopharyngeal carcinoma is highly endemic in Southeast China. Circulating tumor cell is an important biomarker in the prognosis of variety kinds of cancers. Overexpression of fibronectin 1 was observed in variety kinds of malignancies and may contribute to progress and metastasis of the cancers. The current study was aimed to investigate phenotypes of circulating tumor cell in nasopharyngeal carcinoma...
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
Mon Apr 13, 2020 14:04
Inhibition of PTEN Gene Expression by Small Interfering RNA on PI3K/Akt/FoxO3a Signaling Pathway in Human Nasopharyngeal Carcinoma
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. The objective of this article is to study the effect of inhibiting phosphatase and tensin homolog deleted chromatosome 10 gene on phosphoinositide 3-kinase/protein kinase B (Akt)/Forkhead homeobox O3a signaling pathway in human nasopharyngeal carcinoma HK-1 cells. Nasopharyngeal carcinoma HK-1 cell lines were divided into PTEN gene interference group (siPTEN), nonspecific small interfering RNA group (siNC), empty...
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
Mon Apr 13, 2020 13:03
MiR-19-3p Induces Tumor Cell Apoptosis via Targeting FAS in Rectal Cancer Cells
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. MicroRNAs are reported as a vital important factor in cancer cell initiation and progression processes. MicroRNA-19-3p has drawn the attention of many researchers in recent years because of its wide expression and its key role in serious kinds of tumor cells. However, the detailed mechanism of microRNA-19a-3p in these tumors is still poorly understood. So, in the present study, we aimed to explore the biological...
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
Wed Apr 08, 2020 13:03
The Aberrant Expression of MicroRNA-125a-5p/IGF2BP3 Axis in Advanced Gastric Cancer and Its Clinical Relevance
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. RNA-binding proteins have been associated with cancer development. The overexpression of a well-known RNA-binding protein, insulin-like growth factor 2 messenger RNA–binding protein 3, has been identified as an indicator of poor prognosis in patients with various types of cancer. Although gastric cancer is a relatively frequent and potentially fatal malignancy, the mechanism by which insulin-like growth factor...
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
Wed Apr 08, 2020 13:00
Frequency and prognosis of metastasis to liver, lung, bone and brain from Merkel cell carcinoma
Future Oncology, Ahead of Print.
Future Oncology
Tue Apr 21, 2020 12:21
Local management of preinvasive and clinical T1-3 penile cancer: utilization of diverse treatment modalities
Future Oncology, Ahead of Print.
Future Oncology
Fri Apr 17, 2020 15:04
The relationship between leukemia and TP53 gene codon Arg72Pro polymorphism: analysis in a multi-ethnic population
Future Oncology, Ahead of Print.
Future Oncology
Fri Apr 17, 2020 14:44
Acute myeloid leukemia transformed to a targetable disease
Future Oncology, Ahead of Print.
Future Oncology
Thu Apr 16, 2020 13:23
Real-world evidence of NEPA, netupitant-palonosetron, in chemotherapy-induced nausea and vomiting prevention: effects on quality of life
Future Oncology, Ahead of Print.
Future Oncology
Thu Apr 16, 2020 07:18
Stated preferences for relapsed or refractory mantle cell lymphoma treatments in Sweden and Germany
Future Oncology, Ahead of Print.
Future Oncology
Wed Apr 15, 2020 14:45
Functionalized nano-targeted moieties in management of prostate cancer
Future Oncology, Ahead of Print.
Future Oncology
Wed Apr 15, 2020 12:59
Targeted tumor therapy by autophagy of nanoparticles
Future Oncology, Volume 16, Issue 12, Page 793-803, April 2020.
Future Oncology
Wed Apr 15, 2020 12:35
Skin check partner assistance for melanoma skin self-examination by at-risk patients: it takes two to identify melanomas
Future Oncology, Ahead of Print.
Future Oncology
Wed Apr 15, 2020 12:07
Immunotherapy in elderly patients: should we stay or should we go?
Future Oncology, Ahead of Print.
Future Oncology
Tue Apr 14, 2020 14:17
GDC-0941 and CXCL8 (3-72) K11R/G31P combination therapy confers enhanced efficacy against breast cancer
Future Oncology, Ahead of Print.
Future Oncology
Tue Apr 14, 2020 14:13
Risk factors and prognosis of bone metastases in newly diagnosed gastric cancer
Future Oncology, Volume 16, Issue 12, Page 733-748, April 2020.
Future Oncology
Tue Apr 14, 2020 13:33
Real-world use and acceptance of rituximab biosimilars in non-Hodgkin lymphoma in an oncologist network in Germany
Future Oncology, Ahead of Print.
Future Oncology
Tue Apr 14, 2020 07:18
Temozolomide in secondary prevention of HER2-positive breast cancer brain metastases
Future Oncology, Ahead of Print.
Future Oncology
Thu Apr 09, 2020 12:49
Predictive markers of immune response in glioblastoma: hopes and facts
Future Oncology, Ahead of Print.
Future Oncology
Thu Apr 09, 2020 12:38
Treatment and relapse in breast cancer show significant correlations to noninvasive testing using urinary and plasma DNA
Future Oncology, Ahead of Print.
Future Oncology
Thu Apr 09, 2020 12:19
The Lebanese Society of Medical Oncology (LSMO) statement on the care of patients with cancer during the COVID-19 pandemic
Future Oncology, Volume 16, Issue 11, Page 615-617, April 2020.
Future Oncology
Wed Apr 08, 2020 12:47
Kommunikativ-pragmatische Störungen bei Alzheimer-Demenz
Sprache Stimme GehörDOI: 10.1055/a-1043-7822© Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals:Table of contents  |  Full text
Sprache · Stimme · Gehör
Tue Apr 21, 2020 02:00
Rating-Verfahren in der Therapieplanung bei kognitiven Kommunikationsstörungen
Sprache Stimme GehörDOI: 10.1055/a-1043-7259© Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals:Table of contents  |  Full text
Sprache · Stimme · Gehör
Tue Apr 21, 2020 02:00
Prognose der sprachlichen Entwicklung von Late Talkers bis zum Alter von 3 Jahren
Sprache Stimme GehörDOI: 10.1055/a-0867-7927 Hintergrund Es sollte die weitere sprachliche Entwicklung von Kindern, die mit 24 Monaten die Kriterien eines Late Talkers erfüllt hatten und mit 2½ Jahren noch immer als sprachentwicklungsverzögert eingestuft wurden, bis zum Alter von 3 Jahren erfasst werden. Zudem war es Ziel, prognostische Faktoren zu identifizieren, mittels derer ein Auf- bzw. Nicht-Aufholen bis zum Alter von 3 Jahren vorhergesagt werden kann. Methode Mittels...
Sprache · Stimme · Gehör
Tue Apr 21, 2020 02:00

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου

Translate